Scarica l'app Stockscreener
7.25
2.26%
0.16
Precedente Chiudi:
$7.09
Aprire:
$7.245
Volume 24 ore:
5,558
Relative Volume:
0.01
Capitalizzazione di mercato:
$11.92M
Reddito:
$1.47M
Utile/perdita netta:
$-97.61M
Rapporto P/E:
-4.8658
EPS:
-1.49
Flusso di cassa netto:
$-80.90M
1 W Prestazione:
-0.55%
1M Prestazione:
-8.23%
6M Prestazione:
-26.62%
1 anno Prestazione:
-55.52%
Intervallo 1D:
$6.9378
$7.25
Intervallo di 1 settimana:
$6.80
$7.5247
Portata 52W:
$3.8101
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Nome
Lyra Therapeutics Inc
Settore
Industria
Telefono
617-373-4600
Indirizzo
480 ARSENAL WAY, WATERTOWN, MA
Confronta LYRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
7.25 | 12.02M | 1.47M | -97.61M | -80.90M | -1.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.36 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.01 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.31 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.97 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.33 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-07 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-05-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-05-06 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | Ripresa | BTIG Research | Buy |
| 2023-08-31 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-26 | Iniziato | BTIG Research | Buy |
| 2020-05-26 | Iniziato | BofA/Merrill | Buy |
| 2020-05-26 | Iniziato | Jefferies | Buy |
| 2020-05-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Lyra Therapeutics Inc Borsa (LYRA) Ultime notizie
Bollinger Bands Show Potential Breakout in Lyra Therapeutics Inc.Portfolio Update Summary & Weekly High Return Stock Forecasts - thegnnews.com
Published on: 2025-08-20 23:19:46 - classian.co.kr
Screener Results Flag Lyra Therapeutics Inc. as OversoldMarket Volume Summary & Free Expert Verified Stock Movement Alerts - newsyoung.net
Can Lyra Therapeutics Inc. maintain sales growthJuly 2025 EndofMonth & High Return Trade Guides - thegnnews.com
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift - MSN
Building trade automation scripts for Lyra Therapeutics Inc.July 2025 PreEarnings & Low Risk High Reward Ideas - Newser
How to recover losses in Lyra Therapeutics Inc. stockEarnings Beat & Low Risk Entry Point Guides - Newser
Lyra Therapeutics Inc. Attempts Reversal From Key SupportJuly 2025 Price Swings & Risk Controlled Swing Alerts - sundaytimes.kr
Lyra Therapeutics Reports Q2 2025 Financial Results - TipRanks
Healthcare Stocks Under Analyst Spotlight: Lyra Therapeutics, Stoke Therapeutics, and Astria Therapeutics. - AInvest
Cautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects - TipRanks
What to do if you’re stuck in Lyra Therapeutics Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - Newser
Should you wait for a breakout in Lyra Therapeutics Inc.2025 Big Picture & Accurate Entry and Exit Point Alerts - Newser
Lyra Therapeutics shares rise 11.19% intraday after positive ENLIGHTEN 2 Phase 3 results and extended cash runway. - AInvest
Key metrics from Lyra Therapeutics Inc.’s quarterly dataWeekly Investment Summary & Expert Approved Trade Ideas - Newser
Chart based exit strategy for Lyra Therapeutics Inc.2025 Big Picture & High Conviction Buy Zone Picks - Newser
Why Lyra Therapeutics Inc. is moving todayMarket Sentiment Summary & Fast Momentum Stock Entry Tips - Newser
Developing predictive dashboards with Lyra Therapeutics Inc. dataShare Buyback & Free Reliable Trade Execution Plans - Newser
Lyra Therapeutics 2025 Q2 Earnings Significant Loss Reduction - AInvest
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78) - MSN
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Risk vs reward if holding onto Lyra Therapeutics Inc.Market Risk Analysis & Reliable Price Action Trade Plans - Newser
Lyra Therapeutics Q2 2025 Earnings: Revenue of $183K Surpasses Forecast, EPS of -$5.51 Beats Estimate - AInvest
Lyra Therapeutics Posts 85% Drop in Q2 Loss, Positive LYR-210 Clinical Trial Results Position Company for Regulatory Meeting - AInvest
Lyra Therapeutics Posts 85% Q2 Loss Drop - Nasdaq
Can trapped investors hope for a rebound in Lyra Therapeutics Inc.Historical Stock Summary and ROI Review - Newser
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Lyra Therapeutics: Navigating Financial Challenges on the Road to Profitability - AInvest
Lyra Therapeutics Q2 rev. up 9% YoY, cash runway extended to 3Q 2026. - AInvest
LYRA THERAPEUTICS Earnings Results: $LYRA Reports Quarterly Earnings - Quiver Quantitative
Lyra Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Using economic indicators to assess Lyra Therapeutics Inc. potentialInstitutional Holding Behavior Pattern Analysis - Newser
Lyra's Nasal Implant Shows Promise in Phase 3 Trial, Extends Cash Runway Through 2026 - Stock Titan
Real time breakdown of Lyra Therapeutics Inc. stock performanceSwing Trade Signal and Price Prediction - Newser
What makes Lyra Therapeutics Inc. stock price move sharplyPortfolio Allocation Strategy for Stability - Newser
Understanding Lyra Therapeutics Inc.’s price movementOversold Reversal Picks with Buy Zone - Newser
Sentiment analysis tools applied to Lyra Therapeutics Inc.Trade Alert System with Volume Analysis - Newser
Custom strategy builders for tracking Lyra Therapeutics Inc.Free Daily Profit Focused Stock Screener - Newser
Is Lyra Therapeutics Inc. stock reversal real or fakeBuy Strategy Review With Performance Summary - Newser
What earnings revisions data tells us about Lyra Therapeutics Inc.Smart Entry Watchlist with Daily Analysis - Newser
Chart overlay techniques for tracking Lyra Therapeutics Inc.Free Low Risk Picks for Daily Trading - Newser
Lyra Therapeutics Inc. stock trendline breakdownDaily Swing Candidate Analysis with Chart Patterns - Newser
RSI + MACD Show Convergence for Lyra Therapeutics Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Lyra Therapeutics (LYRA) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Published on: 2025-08-11 02:07:15 - Newser
Will Lyra Therapeutics Inc. rebound enough to break evenFree Short Term Trading Opportunity Watch - Newser
Predicting Lyra Therapeutics Inc. trend using moving averagesFree AI Powered High Return Stock Calls - Newser
Is it time to cut losses on Lyra Therapeutics Inc.Free AI-Powered Trade Planning with Indicators - Newser
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionSafe Momentum Strategy With Trend Analysis - Newser
How to use a screener to detect Lyra Therapeutics Inc. breakoutsWeekly High Conviction Trade Setup Analysis - Newser
Is Lyra Therapeutics Inc. stock poised for growthSmart Risk Strategy with Entry Optimization - Newser
Lyra Therapeutics Inc Azioni (LYRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lyra Therapeutics Inc Azioni (LYRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cavalier Jason | Chief Financial Officer |
Jul 10 '25 |
Sale |
8.91 |
684 |
6,094 |
519,316 |
2.44%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):